199 related articles for article (PubMed ID: 36313374)
21. Identification of N6-Methylandenosine-Related lncRNAs for Subtype Identification and Risk Stratification in Gastric Adenocarcinoma.
Huang Y; Yang Z; Huang C; Jiang X; Yan Y; Zhuang K; Wen Y; Liu F; Li P
Front Oncol; 2021; 11():725181. PubMed ID: 34646770
[TBL] [Abstract][Full Text] [Related]
22. Identification of cuproptosis-associated IncRNAs signature and establishment of a novel nomogram for prognosis of stomach adenocarcinoma.
Yu W; Huo H; You Z; Lu R; Yao T; Huang J
Front Genet; 2022; 13():982888. PubMed ID: 36160008
[No Abstract] [Full Text] [Related]
23. Construction of stomach adenocarcinoma prognostic signature based on anoikis-related lncRNAs and clinical significance.
Lu L; Yu M; Huang W; Chen H; Jiang G; Li G
Libyan J Med; 2023 Dec; 18(1):2220153. PubMed ID: 37300839
[TBL] [Abstract][Full Text] [Related]
24. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
Peng Y; Wang H; Huang Q; Wu J; Zhang M
J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
[TBL] [Abstract][Full Text] [Related]
25. Immune cell death-related lncRNA signature as a predictive factor of clinical outcomes and immune checkpoints in gastric cancer.
Zhang Z; Su D; Thakur A; Zhang K; Xia F; Yan Y
Front Pharmacol; 2023; 14():1162995. PubMed ID: 37081965
[No Abstract] [Full Text] [Related]
26. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
[TBL] [Abstract][Full Text] [Related]
27. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
Xu M; Mu J; Wang J; Zhou Q; Wang J
Front Oncol; 2022; 12():961213. PubMed ID: 35965536
[TBL] [Abstract][Full Text] [Related]
28. Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma.
Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M
Front Oncol; 2021; 11():663263. PubMed ID: 34123820
[TBL] [Abstract][Full Text] [Related]
29. Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma.
Liu J; Liu Q; Shen H; Liu Y; Wang Y; Wang G; Du J
Front Genet; 2022; 13():838624. PubMed ID: 35928454
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of a novel endoplasmic reticulum stress-related lncRNA prognostic signature and candidate drugs in breast cancer.
Cai J; Ji Z; Wu J; Chen L; Zheng D; Chen Y; Zhang X; Xie W; Huang J; Chen M; Lin R; Lin W; Chen Y; Li Z
Front Genet; 2022; 13():949314. PubMed ID: 36092873
[TBL] [Abstract][Full Text] [Related]
31. Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma.
Wang X; Qian J; Yao N; Pocha C; Kang KJ; Angelico R; Zhu G
Ann Transl Med; 2022 May; 10(10):595. PubMed ID: 35722420
[TBL] [Abstract][Full Text] [Related]
32. Construction and validation of a novel prognostic model using the cellular senescence-associated long non-coding RNA in gastric cancer: a biological analysis.
Wang G; Mao Z; Zhou X; Zou Y; Zhao M
J Gastrointest Oncol; 2022 Aug; 13(4):1640-1655. PubMed ID: 36092333
[TBL] [Abstract][Full Text] [Related]
33. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.
Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S
Front Genet; 2022; 13():862741. PubMed ID: 35368663
[No Abstract] [Full Text] [Related]
34. Identification and Construction of a Long Noncoding RNA Prognostic Risk Model for Stomach Adenocarcinoma Patients.
Zha Z; Zhang P; Li D; Liu G; Lu L
Dis Markers; 2021; 2021():8895723. PubMed ID: 33680217
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of cuproptosis-related lncRNAs model in tumor immune microenvironment and prognostic value of cervical cancer.
Wang Q; Xu Y
Front Pharmacol; 2022; 13():1065701. PubMed ID: 36532719
[TBL] [Abstract][Full Text] [Related]
36. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
Tan Y; Lu L; Liang X; Chen Y
World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978
[TBL] [Abstract][Full Text] [Related]
37. Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma.
Xu Y; Chen Y; Niu Z; Yang Z; Xing J; Yin X; Guo L; Zhang Q; Yang Y; Han Y
Front Surg; 2022; 9():860806. PubMed ID: 35937602
[TBL] [Abstract][Full Text] [Related]
38. Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma.
Ye Y; Zhao Q; Wu Y; Wang G; Huang Y; Sun W; Zhang M
Front Genet; 2022; 13():989719. PubMed ID: 36212154
[No Abstract] [Full Text] [Related]
39. Applying immune-related lncRNA pairs to construct a prognostic signature and predict the immune landscape of stomach adenocarcinoma.
Wang Y; Zhang X; Dai X; He D
Expert Rev Anticancer Ther; 2021 Oct; 21(10):1161-1170. PubMed ID: 34319826
[No Abstract] [Full Text] [Related]
40. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
Zhao J; Lin X; Zhuang J; He F
Front Genet; 2021; 12():714697. PubMed ID: 34777460
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
